The Literary World
Title | The Literary World PDF eBook |
Author | |
Publisher | |
Pages | 438 |
Release | 1897 |
Genre | |
ISBN |
Le Bulletin Des Recherches Historiques
Title | Le Bulletin Des Recherches Historiques PDF eBook |
Author | |
Publisher | |
Pages | 894 |
Release | 1920 |
Genre | Canada |
ISBN |
Revue Générale Nucléaire
Title | Revue Générale Nucléaire PDF eBook |
Author | |
Publisher | |
Pages | 646 |
Release | 2005 |
Genre | Nuclear energy |
ISBN |
Journal de Trévoux
Title | Journal de Trévoux PDF eBook |
Author | |
Publisher | |
Pages | 600 |
Release | 1968 |
Genre | Trévoux (France) |
ISBN |
RBPH
Title | RBPH PDF eBook |
Author | Société pour le progrès des études philologiques et historiques |
Publisher | |
Pages | 1200 |
Release | 1939 |
Genre | Aryan philology |
ISBN |
Exporting American Architecture, 1870-2000
Title | Exporting American Architecture, 1870-2000 PDF eBook |
Author | Jeffrey W. Cody |
Publisher | Psychology Press |
Pages | 228 |
Release | 2003 |
Genre | Architecture |
ISBN | 9780415299152 |
This unique study examines how North American architecture had been 'transplanted' elsewhere during the twentieth century.
Managing Breast Cancer Risk
Title | Managing Breast Cancer Risk PDF eBook |
Author | Monica Morrow |
Publisher | PMPH-USA |
Pages | 328 |
Release | 2003 |
Genre | Breast |
ISBN | 9781550092608 |
Managing Breast Cancer Risk is a single source for information needed by primary care physicians, nurses, gynecologists, as well as oncologic specialists who deal with women who are concerned about breast cancer. Its purpose is to bring together a multidisciplinary group of experts to address breast cancer risk in a clinically meaningful way. Chapters providing detailed information on individual risk factors are accompanied by a discussion of models, which integrate multiple factors for a more complete assessment of risk. Traditional strategies for risk management, including surveillance and prophylactic surgery, are reviewed, and the data on newer techniques such as ductal lavage and screening with magnetic resonance is presented. The rational for chemoprevention with selective estrogen receptor modulators (SERMS) is discussed, and the evidence for tamoxifen as a chemopreventative is updated. The potential for chemoprevention with newer SERMS and the aromatase inhibitors is reviewed. Finally, the critical (and often ignored) areas of quality of life and symptom management are addressed.